Singular Genomics Systems Inc OMIC

Technology Scientific & Technical Instruments

Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The Company is also engaged in developing PX, which is a development-stage multiomics platform.

NDAQ:OMIC - Post by User

Singular Genomics Systems Inc

<< Previous

Bullboard Posts

Post by whytestockson Sep 12, 2024 8:02pm

38 Views

Post# 36221433

Singular Genomics Receives Non-Binding Acquisition Proposal

NEWS: $OMIC Singular Genomics Receives Non-Binding Acquisition Proposal from DeerfieldSAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received a non-binding proposal from Dee...OMIC - Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield

<< Previous

Bullboard Posts

Eminent acquires promising Nevada gold project